Logo

American Heart Association

  118
  0


Final ID: Su3050

Aortic Valve Neocuspidization Using Autologous Insertion Of Pulmonary SinusTm: A Proof Of Concept

Abstract Body (Do not enter title and authors here): Objectives: We developed and evaluated a novel aortic valve neocuspidization technique using autologous pulmonary sinuses in an ex-vivo porcine model. Human anatomical feasibility was assessed using retrospective 3D-echocardiographic data from children.
Methods: Pulmonary sinuses harvested from porcine hearts were used to construct tri-leaflet valves, within native aortas (n=2, 26-28mm) or a Hemashield conduit (n=1, 26mm). Valves were subjected to hydrodynamic testing at varying cardiac outputs (CO) to simulate physiological aortic conditions. Separately, pulmonary sinus and aortic cusp dimensions were compared in 9 children (3-15y) with structurally normal valves using 3D-echocardiography to confirm anatomical feasibility.
Results: All valves were able to sustain goal CO and MAP (100mmHg). The regurgitation fraction in Hemashield was 9-15% at 5L/min and 6-12% at 7L/min and in aorta, it was 11-21% and 5-15% at 5 and 7L/min, respectively, consistent with non-clinically significant regurgitation. Effective orifice area was 2.44cm2 in Hemashield and 1.05-1.07cm2 in native aortas. Peak pressure was 11-21mmHg (Hemashield) and 49-103mmHg (aorta). On pediatric 3D-echocardiographic analysis, there was a strong to excellent correlation between pulmonary sinus and aortic cusp dimensions: effective height (Correlation coefficient, r=0.83, p=0.006), geometric height (r =0.88, p=0.002), and intercommissural width (r=0.97, p<0.001).
Conclusions: In an ex-vivo model, pulmonary sinuses functioned effectively as aortic neocusps with the expected afterload and CO. Pediatric 3D-echocardiography confirmed anatomical suitability. Given limited options in children, this technique may offer an alternative for aortic valve reconstruction using autologous tissue.
  • Faateh, Muhammad  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Raees, Muhammad Aanish  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Ahmed, Hosam  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Almiqlash, Bushray  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Villalobos Lizardi, Jose  ( Cincinnati Children's Hospital , Cincinnati , Ohio , United States )
  • Ricci, Marco  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Ashfaq, Awais  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Author Disclosures:
    Muhammad Faateh: No Answer | Muhammad Aanish Raees: No Answer | Hosam Ahmed: No Answer | Bushray Almiqlash: DO NOT have relevant financial relationships | Jose Villalobos Lizardi: DO NOT have relevant financial relationships | Marco Ricci: DO NOT have relevant financial relationships | Awais Ashfaq: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Technologic and Clinical Advances in CHD Care

Sunday, 11/09/2025 , 11:30AM - 12:30PM

Abstract Poster Board Session

More abstracts on this topic:
Proximity barcoding assay reveals dynamic plasma exosome protein profiles and subpopulation characteristics in patients undergoing transcatheter pulmonary valve replacement

Liang Runzhang, Abudurexiti Naijimuding, Wu Jiaxiong, Ling Jing, Peng Zirui, Wang Canxin, Yuan Haiyun, Wen Shusheng

Atrialized” Minimally Invasive Transcatheter Mitral Valve-In-MAC Replacement to Prevent Outflow Tract Obstruction

Steafo Lark, Smielewski Mitchell, Madanat Luai, Bloomingdale Richard, Jabri Ahmad, Gallagher Michael, Birk Vishal, Abbas Amr, Young John, Suri Rakesh

You have to be authorized to contact abstract author. Please, Login
Not Available